Ainos, Inc.
- AIMD
- NASDAQ
- Biotechnology
- Point-of-Care Diagnostics
- Rapid Test Kits
$0.99
Today +7.17%Quote Oct 19, 2026, 04:57 PM UTC
−38.00%over the last month
Max drawdown −38.0%From 1-month high −38.0%3 months −41.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Ainos
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
41
Market value
$7.3M
Quote Oct 19
Floor
$0.93
6.1% below price
Resistance
$1.05
6.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about AIMDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free